T1D Therapy and Management

T1D Therapy and Management

Insulin is the mainstay therapy for T1D. New types of insulin, modern glucose monitoring, and insulin administration techniques have made it easier for insulin levels in patients with type 1 diabetes to more closely mimic those in healthy individuals. Insulin treatment can be rapid acting, short acting, intermediate acting and long acting, these may be administered via daily injections and/or insulin pumps which reduce the frequency of injections. 

The use of non-insulin add-on treatment is a new trend. It has been successfully used in laboratories as well as clinical trials. Metformin is the most widely used drug, together with sodium-glucose co-transporters 2 (SGLT2) inhibitors, amylin analogues, glucagon-like peptide 1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors. The results of administration of these medications give good outcomes in patients with T1D.